Jefferies Financial Group Initiates Coverage on Axsome Therapeutics (NASDAQ:AXSM)
Jefferies Financial Group started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The brokerage issued a buy rating and a $200.00 price objective on the stock. AXSM has been the topic of several other reports. William Blair reaffirmed an “outperform” rating […]
Jefferies Financial Group started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The brokerage issued a buy rating and a $200.00 price objective on the stock. AXSM has been the topic of several other reports. William Blair reaffirmed an “outperform” rating […]
